Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 6
1952 3
1953 1
1954 7
1955 5
1956 3
1957 4
1958 3
1959 3
1960 7
1961 6
1962 12
1963 3
1964 3
1965 2
1966 5
1967 3
1968 2
1969 6
1970 1
1971 5
1972 7
1974 1
1975 1
1976 2
1977 13
1978 6
1979 4
1980 2
1981 7
1982 2
1983 2
1984 3
1985 2
1986 7
1987 3
1988 1
1989 8
1990 4
1991 3
1992 1
1993 2
1995 1
1999 1
2015 1
2016 5
2017 1
2018 5
2019 4
2020 3
2021 6
2022 7
2023 6
2024 2
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

213 results

Results by year

Filters applied: . Clear all
Page 1
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group. Bateman RJ, et al. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. N Engl J Med. 2023. PMID: 37966285 Free PMC article. Clinical Trial.
Extended amantadine-induced livedo reticularis.
Vollhardt R, Budowski C, Manceau P, Mongin M, Degos B. Vollhardt R, et al. Among authors: mongin m. Rev Neurol (Paris). 2021 Dec;177(10):1301-1303. doi: 10.1016/j.neurol.2021.02.395. Epub 2021 Jul 3. Rev Neurol (Paris). 2021. PMID: 34229870 No abstract available.
A Double-Blind, Randomized, Placebo-Controlled Trial of Bumetanide in Parkinson's Disease.
Damier P, Degos B, Castelonovo G, Anheim M, Benatru I, Carrière N, Colin O, Defebvre L, Deverdal M, Eusebio A, Ferrier V, Giordana C, Houeto JL, Le Dily S, Mongin M, Thiriez C, Tranchant C, Ravel D, Corvol JC, Rascol O, Ben Ari Y. Damier P, et al. Among authors: mongin m. Mov Disord. 2024 Mar;39(3):618-622. doi: 10.1002/mds.29726. Epub 2024 Jan 30. Mov Disord. 2024. PMID: 38291616 Clinical Trial.
Classification of GBA1 variants and their impact on Parkinson's disease: an in silico score analysis.
Lanore A, Tesson C, Basset A, Lejeune FX, Cogan G, Mangone G, Sambin S, Bertille N, Anheim M, Arnulf I, Ansquer S, Brandel JP, Brefel-Courbon C, Defebvre L, Drapier S, Eusebsio A, Fabbri M, Giordana C, Hainque E, Lehericy S, Marques A, Moreau C, Moro E, Ory F, Rolland AS, Thobois S, Vidailhet M, Devos D, Mariani LL, Lesage S, Brice A, Corvol JC; Predistim study group; Iceberg study group; NSPark study group. Lanore A, et al. NPJ Parkinsons Dis. 2025 Aug 2;11(1):226. doi: 10.1038/s41531-025-01060-6. NPJ Parkinsons Dis. 2025. PMID: 40753162 Free PMC article.
[Erythromycine].
MONGIN M. MONGIN M. Mars Med. 1955;92(6):368-72. Mars Med. 1955. PMID: 14393121 French. No abstract available.
[Terramycin].
MONGIN M. MONGIN M. Mars Med. 1952;89(10):539-45. Mars Med. 1952. PMID: 13012258 Undetermined Language. No abstract available.
[Movement disorders in the elderly].
Doridam J, Mongin M, Degos B. Doridam J, et al. Among authors: mongin m. Geriatr Psychol Neuropsychiatr Vieil. 2019 Dec 1;17(4):395-404. doi: 10.1684/pnv.2019.0825. Geriatr Psychol Neuropsychiatr Vieil. 2019. PMID: 31848126 French.
Balint's syndrome revealing Creutzfeldt-Jakob disease.
Escalere M, Joly C, Palisson J, Budowski C, Mongin M, Degos B. Escalere M, et al. Among authors: mongin m. Rev Neurol (Paris). 2022 Mar;178(3):278-280. doi: 10.1016/j.neurol.2021.04.012. Epub 2021 Jul 15. Rev Neurol (Paris). 2022. PMID: 34274131 No abstract available.
Validation of the French Translation of the Movement Disorder Society Non-Motor Symptoms Scale (MDS-NMS) in Parkinson's Disease.
Desjardins C, Grimaldi S, Luo S, Yu L, Goetz CG, Stebbins GT, Martinez-Martin P, Kurtis MM, Mestre TA, Sanchez-Ferro A, Tosin MHS, Balestrino R, Lin CR, Gasca-Salas C, Witjas T, Colin O, Maltete D, Defebvre L, Giordana C, Charif M, Thiriez C, Laurencin C, Tir M, Dupont G, Remy P, Tranchant C, Drapier S, Samier A, Benatru I, Sambin S, Corvol JC, Kelifi F, Fabbri M, Rascol O; NS‐Part Cohort study group and the MDS COA Translation Steering Committee. Desjardins C, et al. Mov Disord Clin Pract. 2025 Sep 1. doi: 10.1002/mdc3.70323. Online ahead of print. Mov Disord Clin Pract. 2025. PMID: 40888151 No abstract available.
213 results